ESC CVD Risk Calculation
ASO Keyword Dashboard
Tracking 76 keywords for ESC CVD Risk Calculation in Google Play
ESC CVD Risk Calculation tracks 76 keywords (no keywords rank yet; 76 need traction). Key metrics: opportunity 69.7, difficulty 44.7.
Individual cardiovascular risk assessment for healthcare professionals
Tracked keywords
76
0 ranked • 76 not ranking yet
Top 10 coverage
—
Best rank — • Latest leader —
Avg opportunity
69.7
Top keyword: upon
Avg difficulty
44.7
Lower scores indicate easier wins
Opportunity leaders
- 67.5
upon
Opportunity: 73.0 • Difficulty: 44.4 • Rank —
Competitors: 753
- 67.7
stored
Opportunity: 73.0 • Difficulty: 60.5 • Rank —
Competitors: 1,026
- 67.7
intended
Opportunity: 73.0 • Difficulty: 56.3 • Rank —
Competitors: 786
- 69.3
source
Opportunity: 72.0 • Difficulty: 52.0 • Rank —
Competitors: 959
- 70.2
medical
Opportunity: 72.0 • Difficulty: 44.6 • Rank —
Competitors: 802
Unranked opportunities
upon
Opportunity: 73.0 • Difficulty: 44.4 • Competitors: 753
stored
Opportunity: 73.0 • Difficulty: 60.5 • Competitors: 1,026
intended
Opportunity: 73.0 • Difficulty: 56.3 • Competitors: 786
source
Opportunity: 72.0 • Difficulty: 52.0 • Competitors: 959
medical
Opportunity: 72.0 • Difficulty: 44.6 • Competitors: 802
High competition keywords
features
Total apps: 116,743 • Major competitors: 14,116
Latest rank: — • Difficulty: 64.6
designed
Total apps: 96,808 • Major competitors: 9,110
Latest rank: — • Difficulty: 56.6
available
Total apps: 92,463 • Major competitors: 9,952
Latest rank: — • Difficulty: 66.4
online
Total apps: 80,029 • Major competitors: 9,770
Latest rank: — • Difficulty: 60.8
various
Total apps: 74,125 • Major competitors: 9,464
Latest rank: — • Difficulty: 57.7
All tracked keywords
Includes opportunity, difficulty, rankings and competitor benchmarks
| Major Competitors | |||||||
|---|---|---|---|---|---|---|---|
| online | 66 | 100 | 61 | 84 80,029 competing apps Median installs: 33,297 Avg rating: 2.8 | — | — | 9,770 major competitor apps |
| collaboration | 71 | 100 | 47 | 60 3,380 competing apps Median installs: 22,040 Avg rating: 2.5 | — | — | 274 major competitor apps |
| source | 72 | 100 | 52 | 69 11,396 competing apps Median installs: 27,566 Avg rating: 2.9 | — | — | 959 major competitor apps |
| support | 67 | 100 | 60 | 83 68,575 competing apps Median installs: 34,249 Avg rating: 3.0 | — | — | 7,371 major competitor apps |
| within | 68 | 100 | 56 | 80 45,953 competing apps Median installs: 29,549 Avg rating: 2.8 | — | — | 4,617 major competitor apps |
| individual | 71 | 100 | 54 | 71 15,144 competing apps Median installs: 20,930 Avg rating: 2.6 | — | — | 1,085 major competitor apps |
| medical | 72 | 100 | 45 | 70 12,810 competing apps Median installs: 23,738 Avg rating: 2.6 | — | — | 802 major competitor apps |
| designed | 66 | 100 | 57 | 85 96,808 competing apps Median installs: 27,484 Avg rating: 2.8 | — | — | 9,110 major competitor apps |
| educational | 70 | 100 | 49 | 74 22,073 competing apps Median installs: 26,231 Avg rating: 2.5 | — | — | 2,042 major competitor apps |
| connection | 69 | 100 | 60 | 76 29,202 competing apps Median installs: 32,388 Avg rating: 2.9 | — | — | 3,022 major competitor apps |
| available | 66 | 100 | 66 | 85 92,463 competing apps Median installs: 34,120 Avg rating: 2.9 | — | — | 9,952 major competitor apps |
| provide | 67 | 100 | 55 | 82 61,536 competing apps Median installs: 28,348 Avg rating: 2.7 | — | — | 5,453 major competitor apps |
| university | 72 | 100 | 41 | 64 5,845 competing apps Median installs: 14,036 Avg rating: 2.2 | — | — | 164 major competitor apps |
| various | 67 | 100 | 58 | 83 74,125 competing apps Median installs: 40,134 Avg rating: 2.8 | — | — | 9,464 major competitor apps |
| healthcare | 72 | 100 | 41 | 63 5,145 competing apps Median installs: 21,293 Avg rating: 2.6 | — | — | 291 major competitor apps |
| provides | 67 | 100 | 60 | 83 71,787 competing apps Median installs: 26,302 Avg rating: 2.7 | — | — | 6,088 major competitor apps |
| patient | 71 | 100 | 38 | 61 3,718 competing apps Median installs: 18,204 Avg rating: 2.6 | — | — | 190 major competitor apps |
| powered | 72 | 100 | 82 | 70 12,785 competing apps Median installs: 29,315 Avg rating: 3.1 | — | — | 1,436 major competitor apps |
| center | 72 | 100 | 48 | 69 11,147 competing apps Median installs: 31,391 Avg rating: 2.7 | — | — | 1,133 major competitor apps |
| upon | 73 | 100 | 44 | 67 8,881 competing apps Median installs: 28,496 Avg rating: 2.8 | — | — | 753 major competitor apps |
| professionals | 72 | 100 | 43 | 67 8,269 competing apps Median installs: 17,969 Avg rating: 2.5 | — | — | 466 major competitor apps |
| internet | 67 | 100 | 57 | 82 62,322 competing apps Median installs: 30,196 Avg rating: 2.8 | — | — | 5,670 major competitor apps |
| influence | 71 | 100 | 38 | 58 2,459 competing apps Median installs: 30,775 Avg rating: 3.0 | — | — | 236 major competitor apps |
| calculation | 72 | 100 | 43 | 64 5,305 competing apps Median installs: 28,825 Avg rating: 2.5 | — | — | 344 major competitor apps |
| includes | 69 | 100 | 54 | 77 33,489 competing apps Median installs: 30,818 Avg rating: 2.9 | — | — | 3,100 major competitor apps |
App Description
Individual cardiovascular risk assessment for healthcare professionals
SCORE2
SCORE2-OP
SCORE2-Diabetes
ASCVD
SMART
SMART-REACH*
DIAL*
LIFE-CVD*
* Available online on U-Prevent (Internet connection required)
The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.
This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.
This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.
The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.
The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific contents within the Application.
